Psychosocial Cancer Care Has Direct Ties to QOL, Emotional Well-Being

News
Video

Organizations such as ASCO and ESMO recognize the importance of integrating psychosocial care into cancer treatment.

The accessibility of psychosocial care correlates directly with the emotional well-being, quality of life, and treatment adherence of patients as they go through their cancer treatment, according to Cristiane Decat Bergerot, PhD, MS.

After the announcement of the first ever World Psycho-Oncology Day, CancerNetwork® spoke with Bergerot about the growing field of psycho-oncology and its importance in the current landscape of cancer care. As she said, a cancer diagnosis can lead to psychological distress and uncertainty, but proper care such as emotional support and counseling can mitigate those effects.

Over the years, the field has become more prominent and is now acknowledged by the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO), among other major organizations in oncology.

Bergerot is a psychologist, the head of supportive care at Grupo Oncoclínicas in Brazil, and a member of the International Psycho-Oncology Society.

Transcript:

Accessible psychosocial care is essential in cancer treatment because it directly impacts a patient’s emotional well-being, treatment adherence, and overall quality of life. We know that a cancer diagnosis brings significant psychological distress and uncertainty, which can affect decision-making and coping mechanisms. When psychosocial care is integrated into cancer care, patients receive the emotional support, counseling, and coping strategies needed to navigate treatment more effectively.

The growing body of research on psycho-oncology has significantly influenced clinical guidelines, treatment protocols, and research priorities in cancer care. We are now seeing many national [and] international oncology organizations, including ASCO and ESMO, emphasize the importance of integrating psychosocial care into standard cancer treatment. This has led to the inclusion of distress screenings in routine clinical assessments and recommendations for early palliative care involvement. Additionally, research on quality of life and patient-reported outcomes has shaped the development of more patient-centered treatment plans, ensuring that interventions address not just survival but also emotional and psychological well-being. As a result, cancer care is becoming increasingly multidisciplinary with psychosocial factors [and is] considered an [important] component of comprehensive treatment.

Reference

World Psycho-Oncology Day (WPOD). IPOS. Accessed April 2, 2025. https://tinyurl.com/43c9rr2c

Recent Videos
Patients with AML will experience different toxicities based on the treatment they receive, whether it is intensive chemotherapy or targeted therapy.
A younger patient with AML who is more fit may be eligible for different treatments than an older patient with chronic medical conditions.
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Genetic backgrounds and ancestry may hold clues for better understanding pancreatic cancer, which may subsequently mitigate different disparities.
Factors like genetic mutations and smoking may represent red flags in pancreatic cancer detection, said Jose G. Trevino, II, MD, FACS.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
Numerous clinical trials vindicating the addition of immunotherapy to first-line chemotherapy in SCLC have emerged over the last several years.
According to John Henson, MD, “What we need are better treatments to control the [brain] tumor once it’s detected.”
First-degree relatives of patients who passed away from pancreatic cancer should be genetically tested to identify their risk for the disease.
Related Content